title: Suppressed parathyroid hormone response to oral and intravenous calcium-calcitriol treatment in chronic renal failure.
authors.forename: H
authors.initials: H
authors.lastname: Taşkapan
authors.forename: I
authors.initials: I
authors.lastname: Karayaylali
authors.forename: N
authors.initials: N
authors.lastname: Seyrek
authors.forename: K
authors.initials: K
authors.lastname: Yildizer
authors.forename: S M
authors.initials: SM
authors.lastname: Adam
authors.forename: E
authors.initials: E
authors.lastname: Gürbüz
authors.forename: S
authors.initials: S
authors.lastname: Paydaş
authors.forename: Y
authors.initials: Y
authors.lastname: Sagliker
mesh_terms: D000328:Adult; D002117:Calcitriol / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*
chemical_list: D010281:Parathyroid Hormone; D002117:Calcitriol; D002118:Calcium